Print this!  Bookmark and Share

Presentations

2014 | 2012 | 2011 | 2010 | 2009 | 2008


Top of page

 

2014


  Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism. Hsiao W. 56th ASH Annual Meeting and Exposition, 2014; San Francisco, CA.

2012


  Disparities in Antihypertensive Medication Adherence: Opportunities for Early Intervention. Adams AS. 18th Annual HMO Research Network Conference, 2012; Seattle, WA.

  Early Persistence with Medicines for Hypertension and Depression in a Multiethnic Cohort. Adams AS. AcademyHealth's 2012 Annual Research Meeting (ARM), 2012; Orlando, FL.

  Trial Evidence‐Based Inclusion and Exclusion Criteria for Primary Prevention Implantable Cardioverter Defibrillators in the Cardiovascular Research Network.Greenlee RT. 18th Annual HMO Research Network Conference, 2012; Seattle, WA.

  A new risk model to predict stroke in Atrial Fibrillation. Singer DE. AHA International Stroke Conference, 2012; New Orleans, LA.

2011


  Prevalence of Overweight and Elevated Blood Pressure in a Large Cohort of Children and Adolescents (Age 3-17 Years) at an Initial Clinic Examination. Adams, K. American Society of Hypertension 26th Annual Scientific Meeting and Exposition, 2011; New York, NY.

  HMORN Research on Pediatric Hypertension and Obesity: Predictors, Care, and Costs: Design of a New Pediatric Cohort. Adams, K. 17th Annual HMO Research Network Conference, 2011; Boston, MA.

  Self-Reported Medication Adherence in 14,246 Patients with Atrial Fibrillation from the ATRIA2-CVRN Study. Black MH. AHA Quality of Care and Outcomes Research Scientific Sessions, 2011; Washington, D.C.

  Patterns of Care in Children and Adolescents Following a First Elevated Blood Pressure Measurement: A Multi-Site Cohort Study. Daley MF. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting, 2011; Denver, CO.

  Contemporary Rates and Predictors of Hospitalization and Death in Heart Failure with Preserved Systolic Function. Go, AS. AHA Scientific Sessions, 2011; Orlando, FL.

  Linking Disparate Data Sources to Evaluate Implantable Cardioverter Defibrillator Outcomes in the Cardiovascular Research Network: Initial Lessons. Greenlee, RT. 17th Annual HMO Research Network Conference, 2011; Boston, MA.

  The Association of Delays in Clopidogrel Filling and Gaps in Subsequent Refills with Adverse Outcomes. Ho PM. Optimizing Efficiency and Quality of Cardiovascular Care Conference, 2011; Denver, CO.

  Comparative Effectiveness Research. Magid, DJ. 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2011; Chicago, IL.

  Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background. Masoudi FA. AHRQ Annual Conference, 2011; Bethesda, MD.

  Longitudinal Study of Implantable Cardioverter Defibrillators (ICDs). Greenlee RT, Masoudi FA. AHRQ Annual Conference, 2011; Bethesda, MD.

  Nine-Year Trends in the Annual Rate of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN), 2000–2008. Reynolds K. AHA EPI/NPAM Scientific Sessions, 2011; Atlanta, GA.

  Health Literacy and Awareness of Atrial Fibrillation: the ATRIA2-CVRN Study. Reynolds K. European Society of Cardiology Congress, 2011; Paris, France.

  Nine-Year Trends in the Annual Rate of Hospitalized Stroke in the Cardiovascular Research Network, 2000–2008. Sidney S. AHA EPI/NPAM Scientific Sessions, 2011; Atlanta, GA.

2010


  Gender Differences in Ambulatory Hypertension Management: Are women and men equally recognized, treated and controlled?.  Daugherty SL. AHA EPI/NPAM Scientific Sessions, 2010; San Francisco, CA.

  Development of a New Risk Stratification Scheme to Predict Warfarin-Associated Hemorrhage: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. Fang MC. AHA Scientific Sessions, 2010; Chicago, IL.

  Quality of Anticoagulation Management in Atrial Fibrillation and Venous Thromboembolism: The CVRN WAVE Study. Go AS. AHA Scientific Sessions, 2010; Chicago, IL.

  Contemporary Rates and Correlates of Warfarin Use in 33,570 Adults with Atrial Fibrillation: The ATRIA2-CVRN Study. Go AS, Singer DE. AHA Scientific Sessions, 2010; Chicago, IL.

  Medication Adherence: What do we need to do to get people to take their medications?. Ho PM. Duke sponsored Think Tank; McLean, VA.

  Why Don't People Take Their Medications? Improving Adherence in 2010. Ho PM. AHA Scientific Sessions, 2010; Chicago, IL.

  Treatment Intensification and Medication Adherence are Factors in Improving Blood Pressure Trajectories Among Newly Diagnosed CAD Patients. Maddox T. AHA Quality of Care and Outcomes Research Scientific Sessions, 2010; Washington, D.C.

  Design and Implementation of a Multi-center Cardiovascular Consortium. Magid DJ. AHRQ Annual Meeting, 2010; Washington, D.C.

  The Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter Defibrillators: ICD Therapy in a Community Population. Masoudi FA, Greenlee RT. AHA Scientific Sessions, 2010; Chicago, IL.

  Building the Hypertension Registry: Adventures in Using the VDW Model. Tavel HM. 16th Annual HMO Research Network Conference, 2010; Austin, TX.

  Post-Discharge Bleeding is Associated with Early Myocardial Infarction and Death after DES Implantation: Insights from the HMO Research Network-Stent Registry (HMORN-Stent). Tsai T. American College of Cardiology 59th Annual Scientific Session, 2010; Atlanta, GA.

2009


  Longitudinal ICD Projects and the Cardiovascular Research Network. Go, AS. Heart Rhythm Society Annual Scientific Sessions, 2009; San Francisco, CA.

  Comparative Effectiveness of 2nd-Line Anti-Hypertensive Therapy. Magid DJ. AHRQ Annual Meeting, 2009; Washington, D.C.

  Two Year Outcomes Following Off-Label Use of Drug-Eluting Stents in the Real World: Insights from the HMO Research Network-Stent Registry (HMORN-STENT). Tsai T. American College of Cardiology 58th Annual Scientific Sessions, 2009; Orlando, FL.

  Increased Risk of Bleeding in Patients On Clopidogrel Therapy After Drug-Eluting Stent Implantation: Insights from the HMO Research Network-Stent Registry (HMORN-Stent). Tsai T. AHA Quality of Care and Outcomes Research Scientific Sessions, 2009; Bellevue, Washington.

  Effect of Clopidogrel Use on Death and Myocardial Infarction in Patients Who Receive Drug Eluting Stents for "Off Label" versus "On Label" Indications: Insights from the HMO Research Network-Stent Registry (HMORN-STENT). Tsai T. AHA Quality of Care and Outcomes Research Scientific Sessions, 2009; Bellevue, Washington.

2008


  The Design and Implementation of the Cardiovascular Data Network Data Systems. Magid DJ. AHA Quality of Care and Outcomes Research Scientific Sessions, 2008; Washington, D.C.

  The Cardiovascular Research Network: Challenges and Opportunities. Magid DJ. Advanced Medical Technology Association National Meeting, 2008; Washington, D.C.